BriaCell Therapeutics Corp. (BCTX): Net earnings per share growth forecast for next year

Public company logo of BriaCell (BCTX)

Is it worth investing in BriaCell Therapeutics (BCTX), given the dependence on funding and the outcome of immunotherapy trials? The GURU.Markets platform features this chart, where the valuation of future earnings per share growth has reached 0.00. The asset is burdened by a lack of revenue and the risk of losing ground to new drugs, while cellular product manufacturing lines are fully utilized for current research.

BCTX: BriaCell Therapeutics Corp Net earnings per share growth forecast for next year 07/04/2022 - 11/15/2026

BCTX (BriaCell): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Price BriaCell Therapeutics Corp.|BCTX - Average Forecast Price
- stock exchange capitalization data:
Market Value BriaCell Corp|BCTX - Business Value
- company book value details:
Book Value per Share BriaCell|BCTX - Company Book Value|Market Value to Book Value Ratio briacell.com|BCTX - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Capital BriaCell Therapeutics|BCTX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital BriaCell Therapeutics Corp.|BCTX - Company Aggregate Debts|Debts to Book Capitalization BriaCell Therapeutics Corp|BCTX - Company Long-Term Liabilities|Company Short-Term Debts BriaCell|Quick Liquidity briacell.com
- earnings and valuation multiples information:
BCTX - Company Net Income|Expected Profit BriaCell Therapeutics|BCTX - Price to Earnings Ratio|Projected Price to Earnings BriaCell|BCTX - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio BriaCell|BCTX - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) BriaCell|BCTX - Earnings per share for the trailing year|Quarterly EPS earnings growth briacell.com|BCTX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year BriaCell Therapeutics
- company sales and revenue statistics:
BCTX - Company Sales Revenue|Projected Sales Volume BriaCell Corp|BCTX - P/S Multiple|Price-to-Projected Revenue Ratio BriaCell Therapeutics|BCTX - Trailing Twelve Months Sales Growth
Basic company analysis:briacell.com, BCTX
Finished products of briacell.com

This indicator measures the expected earnings per share (EPS) growth, reflecting the analysts' consensus forecast for the business's future profitability. For BriaCell Therapeutics (BCTX), this growth depends directly on the commercialization of Bria-IMT patent protocols and the scaling of the cell therapy system. By analyzing the forward-looking EPS growth forecast, an investor can assess the asset's fundamental stability and the risk of overpaying for future success.

Analysis of competing companies

MRUS (Merus NV) - Earnings growth forecast for next year|Expected net earnings per share growth next year immutep.com IMMP|Net earnings per share growth forecast for next year Anixa Biosciences Inc (ANIX)|Atossa Therapeutics, Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year CNTX (Context Therapeutics)|MRSN - Expected earnings per share growth for next year|EPIX - Net earnings per share growth forecast for next year|Expected earnings per share trend next year QTI (QT Imaging Holdings, Inc.)